Sign In
Buy NVCR
$16.15
+0.330 (+2.09%)
At Close: Jun 03, 2026
NovoCure (NVCR) Q2 2020 Earnings Call Transcript
01:01am, Friday, 31'st Jul 2020
Ladies and gentlemen, thank you for standing by, and welcome to the NovoCure second-quarter 2020 earnings call. Good morning, everyone, and thank you for joining us to review NovoCure's second-quarte
NovoCure Limited (NVCR) CEO Asaf Danziger on Q2 2020 Results - Earnings Call Transcript
03:04pm, Thursday, 30'th Jul 2020
NovoCure Limited (NASDAQ:NVCR) Q2 2020 Results Conference Call July 30, 2020 08:00 AM ET Company Participants Ashley Cordova - Senior Vice President of Finance & Investor Relations Bill Doyle - Ex
NovoCure Limited 2020 Q2 - Results - Earnings Call Presentation
11:20am, Thursday, 30'th Jul 2020
The following slide deck was published by NovoCure Limited in conjunction with their 2020 Q2 earnings call.
Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update
10:00am, Thursday, 30'th Jul 2020
Novocure reported financial results for the quarter ended June 30, 2020, and provided a company update.
Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
11:30am, Tuesday, 28'th Jul 2020
Novocure announced today the recipients of the AACR-Novocure Grants for Tumor Treating Fields Research program.
XBiotech Breakthrough, And Other News: The Good, Bad And Ugly Of Biopharma
06:30am, Saturday, 25'th Jul 2020
XBiotech makes a crucial breakthrough in True Human antibodies development. Novocure begins pivotal Phase 2 trial for brain cancer therapy.
3 Great Healthcare Stocks to Watch
01:37am, Saturday, 25'th Jul 2020
There’s a lot to like about investing in the healthcare sector, so get to know three stocks that make great investments right now.
NovoCure (NVCR) Q2 Earnings Preview: What's in the Cards?
04:33pm, Thursday, 23'rd Jul 2020
NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Type Of Shareholders Make Up NovoCure Limited's (NASDAQ:NVCR) Share Registry?
04:00pm, Thursday, 23'rd Jul 2020
If you want to know who really controls NovoCure Limited (NASDAQ:NVCR), then you'll have to look at the makeup of its...
First Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays
11:30am, Wednesday, 22'nd Jul 2020
The first patient has been enrolled in Novocure's EF-33 phase 2 pilot trial of Tumor Treating Fields delivered using high-intensity arrays.
NovoCure: A Disrupter In Oncology
08:33pm, Monday, 20'th Jul 2020
This disruptive medtech player in oncology is up >7x since I started covering it on Seeking Alpha in 2016.
Dow Jones Giant Merck Inks A New Deal In Lung Cancer — And Shares Pop
02:11pm, Wednesday, 15'th Jul 2020
Novocure and Dow Jones pharmaceutical giant Merck announced a collaboration in non-small cell lung cancer treatment Wednesday — prodding shares of Novocure and Merck stock to pop.
Merck, Novocure Team Up On Lung Cancer Treatment; Trial Set For 2H20
01:10pm, Wednesday, 15'th Jul 2020
Merck (MRK) and Novocure (NVCR) have entered into a clinical trial collaboration agreement to develop Tumor Treating Fields together with Merck’s anti-PD-1 therapy Keytruda (pembrolizumab) for treat
Novocure has entered into a clinical trial collaboration agreement with MSD to develop Tumor Treating Fields together with KEYTRUDA® for NSCLC.
Did Hedge Funds Make The Right Call On NovoCure Limited (NVCR) ?
12:54am, Monday, 13'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
